← Back to Search

Behavioral Intervention

Diabetes Telecoaching for Type 2 Diabetes

N/A

Recruiting

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of Type 2 Diabetes Mellitus

Living with a permanent physical disability such as spinal cord injury (SCI), spina bifida, multiple sclerosis, stroke, etc.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 48 weeks

Awards & highlights

Study Summary

This trialaims to create an AI-based program to help people with disabilities better manage diabetes with personalized lifestyle changes. #diabetes #AI

Who is the study for?

This trial is for people with Type 2 Diabetes who also have a permanent physical disability like spinal cord injury or multiple sclerosis. Participants must be able to speak and read English but can't join if they've had severe heart issues, kidney failure, untreated depression recently, are in another diabetes study, don't have a smartphone, or have uncontrolled blood pressure.Check my eligibility

What is being tested?

The study is testing an AI-assisted program called AI4DM designed to help individuals with disabilities manage their diabetes through lifestyle changes. It's compared against standard attention-control methods to see how effective it is at controlling blood sugar levels.See study design

What are the potential side effects?

Since this trial involves a telecoaching self-management program rather than medication, traditional side effects aren't expected. However, participants may experience stress or frustration if they find the technology challenging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Type 2 Diabetes.

Select...

I live with a permanent physical disability like SCI or MS.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 48 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~48 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Glycemic Management

Secondary outcome measures

Diabetes Quality of life

Dietary intake

Family Support

+7 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: AI4DM Intervention GroupExperimental Treatment1 Intervention

Group II: Attention-control GroupActive Control1 Intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,590 Previous Clinical Trials

2,281,392 Total Patients Enrolled

Media Library

AI4DM (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04927377 — N/A

Type 2 Diabetes Research Study Groups: AI4DM Intervention Group, Attention-control Group

Type 2 Diabetes Clinical Trial 2023: AI4DM Highlights & Side Effects. Trial Name: NCT04927377 — N/A

AI4DM (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04927377 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the conditions for entry into this medical trial?

"To qualify for this medical research, individuals must have a diagnosis of type 2 diabetes mellitus and fall within the 18-65 age bracket. The trial is seeking 90 applicants in total."

Answered by AI

Is this scientific experiment currently enrolling participants?

"According to clinicaltrials.gov, enlistment has closed for this study which was initially published on October 31st 2022 and last updated the same day. Even though enrollment is not possible anymore, there are 910 other medical trials that require participants at present."

Answered by AI

Is participation in this trial confined to individuals under 30?

"In order to take part in this medical trial, patients must be aged between 18 and 65. There are 61 trials available for minors while 771 are specifically designed for seniors."

Answered by AI

Recent research and studies

Medical CareJournal

Internet-based Chronic Disease Self-management

Lorig, Kate R., Philip L. Ritter, Diana D. Laurent, and Kathryn Plant. 2006. “Internet-based Chronic Disease Self-management”. Medical Care. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/01.mlr.0000233678.80203.c1.

clinicaltrials.govStudy

Accessible and Inclusive Diabetes Telecoaching Self-Management Program

Mohanraj Thirumalai 2022. "Accessible and Inclusive Diabetes Telecoaching Self-Management Program". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04927377.